MIB Agents OsteoBites and osTEAo

MIB Agents Osteosarcoma OsteoBites S2 Ep 18: Richard Gorlick, MD & Yifei Wang, MD “Antibody Drug Conjugates for Osteosarcoma” ... Guest Information: Richard Gorlick, MD Division Head, Department of Pediatrics Professor, Department of Pediatrics Patient Care Director, Department of Pediatric Sarcoma Research Laboratory Department Chair, ad interim Sarcoma Medical Oncology, Division of Cancer Me...

MIB Agents OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials” ... Guest Information: Lara E. Davis, MD Associate Professor Knight Cancer Institute Co-Leader, Translational Oncology Research Program Sarcoma Disease Site Leader Oregon Health & Science University Lara Davis, MD graduated from Wellesley College and then went on to receive her medic...

MIB Agents OsteoBites S2 Ep 16:  Julie Lanford, MPH, RD, CSO, LDN a Registered Dietician who will be sharing her expertise on “Nutrition & Cancer Truths & Myths” ... Guest Information: Julie Lanford, MPH, RD, CSO, LDN Wellness Director, Cancer Services Julie received her degree in Biology from North Carolina State University and her Masters in public health nutrition from The Universi...

MIB Agents OsteoBites S2 Ep 15:  Katie Greenzang, MD, EdM from Dana-Farber Cancer Institute/Boston Children’s and Harvard Medical School. Dr. Greenzang will be talking about, “What’s Next?  Osteosarcoma Survivorship”. ... Guest Information: Katie Greenzang, MD, MpH Pediatric oncologist at Dana-Farber/Boston Children’s Hospital Instructor at Harvard Medical School ... Dr. Greenzang comple...

MIB Agents OsteoBites S2 Ep 14:  Lillian Guenther, MD from Dana-Farber Cancer Institute and Harvard Medical School.  Dr. Guenther will be talking about, “Utilizing CRISPR Screening to Identify Novel Genomic Targets for Osteosarcoma” .... Guest Information: Lillian Guenther, MD Dana Farber Cancer Institute ... Dr. Guenther received her bachelor degree from Brown University and her MD from...

MIB Agents OsteoBites S2 Ep 13:  Scott Sauer, PhD on “Preventing Osteosarcoma Lethal Recurrence by Targeting Disseminated Tumor Cells” ... Guest Information: Scott Sauer, PhD Head of Preclinical Discovery Vuja De Sciences, Inc. ( www.vujade-life.com ) ... Dr. Scott Sauer is a cancer researcher with multidisciplinary training in the fields of cancer biology, immunotherapy and organic chemistry...

MIB Agents OsteoBites S2 Ep12: Dan Prince, MD on “Regenerative Surgery for Bone Sarcomas” ... Guest Information: Daniel Prince, MD, MPH Orthopedic Surgeon Memorial Sloan Kettering Cancer Education (MD): Yale University Medical School Board Certifications: Orthopedic Surgery ... Dr. Prince is an Orthopedic Surgeon from Memorial Sloan Kettering Cancer Center on the “MSK Kids” team, specializing in t...

MIB Agents OsteoBites S2 Ep 11:  Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients” ... Guest Information: Ines Lohse, PhD Assistant Scientist University of Miami Center for Therapeutic Innovation ... Dr. Lohse received her PhD from the University of Zurich in 2011. After postdoctoral fellowships at the Princess Margaret Cancer Center (Toronto) a...

MIB Agents OsteoBites S2 Ep 10:  Sumit Gupta, MD, PhD, FRCPC “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer” ... Guest Information: Sumit Gupta, MD, PhD, FRCPC Hospital for Sick Children , Staff Oncologist and Clinician Investigator University of Toronto, Associate Professor Institute for Health Policy, Management and Evaluation, Associate Professor Cancer Resea...

MIB Agents OsteoBites S2 Ep 9: Jane Yanagawa, MD, “Osteosarcoma Lung Metastases” Guest Information: Jane Yanagawa, MD Associate Professor of Thoracic Surgery, UCLA David Geffen School of Medicine, Department of Surgery ... Dr. Yanagawa is a thoracic surgeon at the UCLA David Geffen School of Medicine, Department of Surgery.  She completed her residency at UCSD and her fellowship in Thoracic S...

MIB Agents OsteoBites S2 Ep 8: Chand Khanna DVM, PhD, “A Comparative Approach To Metastasis:  Biology and Therapy” Guest Information: Chand Khanna DVM, PhD Chief Science Officer, Ethos Veterinary Health President, President of Ethos Discovery Dr. Khanna is a well known osteosarcoma expert and researcher.  He is a board-certified diplomate of the American College of Veterinary Internal Me...

MIB Agents OsteoBites S2 Ep7: Corrie Painter, PhD “The Osteosarcoma Project, Patient-Partnered Research Update” Guest Information: Corrie Painter, PhD Deputy Director, Count Me In. OSProject.org Broad Institute of MIT & Harvard Corrie Painter, PhD is the Associate Director of Count Me In and is a research scientist at the Broad Institute of MIT and Harvard.  A trained cancer researcher wi...

MIB Agents OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism” Guest Information: Brian Van Tine, M.D., Ph. D. Associate Professor of Medicine Associate Professor of Pediatrics Washington University in St Louis, Missouri Sarcoma Program Director Co-Director of the Adolescence and Young Adult Program Alvin J. Siteman Cancer Center. Dr. Van Tine has been the head of the Sar...

MIB Agents OsteoBites S2 Ep5: Robbie Majzner, MD on “Unleashing the Pediatric Immune System Against Osteosarcoma and Other Solid Tumors” Guest Information: Robbie Majzner, MD Assistant Professor of Pediatrics Stanford University School of Medicine ... Dr. Majzner is an Assistant Professor of Pediatrics at Stanford University School of Medicine. After graduating with a BA from Columbia University,...

MIB Agents OsteoBites S3 Ep4: Lor Randall, MD, Sarcomatology: A Trans-Disciplinary Approach Guest Information: R. Lor Randall, MD, FACS Professor & Chair, University of California, Davis David Linn Endowed Chair in Orthopaedic Surgery. Dr. Randall’s clinical practice and research focus on musculoskeletal surgical oncology and on building leading-edge, trans-disciplinary teams to combat rare ca...

MIB Agents OsteoBites S2 Ep3: Pete Anderson, MD, PhD of Cleveland Clinic Understanding Lab, Path and Scan Reports and Other Questions Answered. Guest Information: Dr. Pete Anderson is an MIB Agents Board Member and MIB Scientific Advisory Board Member.  He is a professor and practices pediatric hematology oncology at Cleveland Clinic.  He has also practiced at University of Texas MD Ande...

MIB Agents OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD on Genome-Informed Targeted Therapies for Osteosarcoma. Guest Information: Alejandro Sweet-Cordero, MD is a physician-scientist focused on basic and translational sarcoma biology. His interest is in mechanisms driving osteosarcoma and Ewing sarcoma progression, metastasis and therapy resistance.  They use patient-derived xenografts and...

MIB Agents OsteoBites S2 Ep1: Erin Murphy, Associate Professor, Radiation Oncology at Cleveland Clinic:  Radiosurgery and SBRT for Sarcoma”. Guest Information: Erin S. Murphy MD is an Associate Professor in the department of radiation oncology at the Cleveland Clinic. She completed residency at the Cleveland Clinic and a fellowship in pediatric radiation oncology at St. Jude Children’s Resear...

MIB Agents OsteoBites S1 Ep28: Ryan Roberts, MD, PhD. “Dear Lungs, Stop enabling this cancer: Targeting interactions that facilitate osteosarcoma metastasis.” Guest Information: Ryan D. Roberts, MD, PhD Division of Hematology and Oncology- Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases-Wexner Research Institute at Nationwide Children’s Translational Therapeutics Prog...

OsteoBites S1 Ep27: Brian Crompton, MD, “New Genomic Approaches to Understanding Osteosarcoma” ... Brian D. Crompton, MD Assistant Professor of Pediatrics Department of Pediatric Oncology Dana-Farber Cancer Institute ... Dr. Crompton’s research focuses on utilizing genomic and proteomic technologies to identify and validate new therapeutic targets for pediatric solid tumors and to develop non-inva...

MIB Agents OsteoBites S1 Ep25: Sulagna Banerjee, PhD, “Modeling Osteosarcoma in Mice”   Guest Information: *Sulagna Banerjee, PhD Research Scientist, University of Miami Health System Sulagna Banerjee Laboratory Associate Professor, University of Miami’s Miller School of Medicine.   ... Hosted By Ann Graham, OsteoWarrior & MIB Agents President   ... MIB Agents is a leading pedia...

MIB Agents OsteoBites S1 Ep24: Andy Woods & Charles Keller, MD: "Legacy Autopsy” Guest Information: *Andy Woods, BS Senior Research Scientist & Childhood Cancer Dad Children’s Cancer Therapy Development Institute (cc-TDI) *Charles Keller, MD Scientific Director Children’s Cancer Therapy Development Institute (cc-TDI) ... Panelists Information: Shannon McCormick, MIB Ambassador Agent, Osteo...

Lauren: Osteosarcoma Survivor, Sibling of OsteoAngel and MIB Jr. Board Member Each week we feature a survivor of Osteosarcoma on #SurvivorSaturday. This week, we shared a video from our annual MIB FACTOR 2020 Osteosarcoma Conference.  Lauren closed out our conference by sharing hers and her family's story of fighting this disease. Lauren, an MIB Agent Jr Board Member, had us crying, cheering...

MIB Agents OsteoBites S1 Ep23: Brian Flesner, DVM, MS, DACVIM: "Adjuvant Chemotherapy for Canine Osteosarcoma” ... Guest Information: *Brian Flesner, DVM, MS, DACVIM American College of Veterinary Internal Medicine (ACVIM) Assistant Professor of Oncology College of Veterinary Medicine at the University of Missouri ... In addition to studying #osteosarcoma, Dr. Flesner’s research interests include...

MIB Agents OsteoBites S1 Ep22: Damon Reed, MD: "Moffitt Osteosarcoma Research Approach ” Guest Information: * Damon Reed, MD Moffitt Cancer Center Director, Adolescent Young Adult Program Interim Chair of the Dept of of Individualized Cancer Mgmt Asst Professor of Pediatrics, University of South Florida. MIB Agents Scientific Advisory Team Panelists Information: Amanda Levine, OsteoWarrior & P...